Amendments to Constitution

For personal use only

10 November 2021

ASX ANNOUNCEMENT

Amendments to Constitution

ImpediMed Limited (ImpediMed) (ASX:IPD) advises that amendments to its Constitution were approved by a special resolution of shareholders at the Company's Annual General Meeting held on 10 November 2021.

For details of the changes and the purpose of the amendments please refer to the Notice of Annual General Meeting released to the market on 07 October 2021.

A copy of the amended Constitution is attached.

Authorised for release by the Company Secretary of ImpediMed Limited.

Contact Details

Investor relations Contact:

Mike Bassett, ImpediMed

T: [phone]

1. [e-mail]

About ImpediMed

Founded and headquartered in Brisbane, Australia with US and European operations, ImpediMed is a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximise patient health.

ImpediMed produces a family of FDA cleared and CE Marked medical devices, including SOZO® for multiple indications including heart failure, lymphoedema, and protein calorie malnutrition sold in select markets globally.

For more information, visit www.impedimed.com.

About SOZO Digital Health Platform

SOZO, the world's most advanced, noninvasive bioimpedance spectroscopy (BIS) device, delivers a precise snapshot of fluid status and tissue composition in less than 30 seconds. Using ImpediMed's BIS technology, SOZO measures 256 unique data points over a wide spectrum of frequencies from 3 kHz to 1000 kHz. Results are available immediately online for easy data access and sharing across an entire Healthcare system. The FDA-cleared,CE-marked and ARTG-listed digital health platform aids in the early detection of secondary lymphedema, provides fluid status for patients living with heart failure, and can be used to monitor and maintain overall health - all on a single device.

For more information, visit:https://www.impedimed.com/products/sozo/.

For personal use only

Forward-Looking Statements

This announcement contains or may contain forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management.

All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to our ability to expand sales and market acceptance in the US and Australia including our estimates of potential revenues, costs, profitability and financial performance; our ability to develop and commercialise new products including our ability to obtain reimbursement for our products; our expectations with respect to our clinical trials, including enrolment in or completion of our clinical trials and our associated regulatory submissions and approvals; our expectations with respect to the integrity or capabilities of our intellectual property position.

Management believes that these forward-looking statements are reasonable as and when made. You should not place undue reliance on forward-looking statements because they speak only as of the date when made. ImpediMed does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. ImpediMed may not actually achieve the plans, projections or expectations disclosed in forward-looking statements. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

For personal use only

CONSTITUTION OF

IMPEDIMED LIMITED

ACN 089 705 144

For personal use only

A COMPANY LIMITED BY SHARES

Constitution of

IMPEDIMED LIMITED

1. GENERAL

1. Name of Company
   The name of the Company is ImpediMed Limited.
2. Liability of members
   The liability of shareholders is limited.
3. Replaceable rules
   The Replaceable Rules do not apply to the Company.

2. DEFINITIONS AND INTERPRETATION

2.1 Definitions

In these rules unless it is inconsistent with the subject or context in which it is used: 'ASIC' means the Australian and Securities Investments Commission;

'ASX' means, as appropriate, ASX Limited or the securities exchange operated by it, and includes without limitation, any successor.;

'ASX Settlement Operating Rules' means the operating rules of ASX Settlement Pty Limited and, to the extent that they are applicable, the operating rules of the ASX and the operating rules of ASX Clear Pty Limited.

'Board' means the Directors for the time being of the Company;

'business day' means a day defined as such under the Listing Rules;

'call' includes any instalment of a call and any amount due on allotment of any share;

'Chair' includes an acting Chair under rule 10;

'Committee' means a Committee to which powers have been delegated by the Board pursuant to rule 18.7;

'Company' means Impedimed Limited ACN 089 705 144;

page 1

For personal use only

'Director' means a person appointed or elected from time to time to the office of Director of the Company in accordance with these rules and includes any alternate Director duly appointed as a Director;

'dispose' when used in rule 3.7, has the meaning given to that term in the Listing Rules;

'Escrow Period' means, in relation to Restricted Securities, the escrow period applicable to those Restricted Securities.

'Holding Lock' has the meaning given to that term in the Listing Rules;

'Law' means the Corporations Act 2001 (Cth) and the Corporations Regulations 2001 (Cth);

'Listing Rules' means the Listing Rules of ASX and any other rules of ASX which are applicable while the Company is admitted to the Official List of ASX, each as amended or replaced from time to time, except to the extent of any express waiver by ASX;

'Managing Director' means the person appointed to that position pursuant to rule 17.1;

'Marketable Parcel' has the meaning specified in the Listing Rules. 'Office' means the registered office from time to time of the Company; 'Official List' has the meaning specified in the Listing Rules;

'person' and words importing persons include partnerships, associations and corporations unincorporated and incorporated by Ordinance, Act of Parliament or registration as well as individuals;

'Proper ASTC Transfer' has the meaning given to that term in the Law.

'Register' means the register of shareholders of the Company and includes a branch register of shareholders established pursuant to rule 20;

'Registered address' means the address of a shareholder specified on a transfer or any other address of which the shareholder notifies the Company as a place at which the shareholder will accept service of notices;

'Restricted Securities' has the meaning specified in the Listing Rules; 'Restriction Deed' has the meaning specified in the Listing Rules;

'Retiring Director' means a Director who is required to retire under rule 16.1 and a Director who ceases to hold office under rule 16.2;

'rules' means the rules of this constitution as altered or added to from time to time; 'Seal' means the common seal, if any, from time to time, of the Company;

'Secretary' means a person appointed as secretary of the Company and includes any person appointed to perform the duties of secretary;

'securities' includes shares, rights to shares, options to acquire shares and other securities with rights of conversion to equity;

'security holder' means a holder of securities of the Company in accordance with the Law.

page 2